287840 — Intocell Balance Sheet
0.000.00%
- KR₩386bn
- KR₩391bn
- KR₩3bn
Annual balance sheet for Intocell, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
---|---|---|
Period Length: | — | — |
Source: | PROSPECTUS | PROSPECTUS |
Standards: | IFRS | IFRS |
Status: | Final | Final |
Cash and Equivalents | ||
Short Term Investments | ||
Cash and Short Term Investments | 11,013 | 6,958 |
Net Total Accounts Receivable | ||
Net Total Receivables | 202 | 1,265 |
Prepaid Expenses | ||
Total Other Current Assets | ||
Total Current Assets | 17,403 | 13,495 |
Gross Property, Plant And Equipment | ||
Accumulated Depreciation | ||
Net Property, Plant And Equipment | 3,596 | 3,343 |
Net Intangible Assets | ||
Long Term Investments | ||
Other Long Term Assets | ||
Total Assets | 25,943 | 23,711 |
Accrued Expenses | ||
Notes Payable / Short Term Debt | ||
Current Portion of Long Term Debt / Capital Leases | ||
Total Other Current Liabilities | ||
Total Current Liabilities | 10,702 | 13,508 |
Capital Lease Obligations | ||
Total Long Term Debt | ||
Total Debt | ||
Total Other Liabilities | ||
Total Funded Status | ||
Total Liabilities | 12,716 | 16,190 |
Common Stock | ||
Additional Paid In Capital | ||
Retained Earnings (Accumulated Deficit) | ||
Other Equity | ||
Total Equity | 13,227 | 7,521 |
Total Liabilities & Shareholders' Equity | 25,943 | 23,711 |
Total Common Shares Outstanding |